Last reviewed: May 16, 2026
Last updated: May 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
Fella Health pricing typically includes a consultation fee, prescription cost, and ongoing medication expenses, though exact totals depend on insurance coverage and pharmacy rates. Most telemedicine weight management programs charge $150–$300 monthly for consultations plus separate medication costs, which can range from $200–$600 per month depending on drug type and supply.
For patients exploring GLP-1 treatment options, understanding the full cost structure—including consultation fees, medication formulation type, and whether genetic or biomarker data might inform dosing—is essential for making informed decisions. PlexusDx brings precision-wellness framing to this evaluation, using genetic predisposition data alongside clinical assessment to support more personalized conversations with providers about both medication choice and expected costs.
Telemedicine Consultation and Program Fees: What's Included
Telemedicine weight management programs like Fella Health typically charge separate fees for initial consultation, ongoing provider visits, and medication dispensing. Consultation fees range from $150–$250 for intake and assessment, with follow-up visits costing $75–$150 quarterly, depending on program tier and provider demand in your region.
These fees cover medical history review, contraindication screening, prescription issuance, and side effect monitoring—services that reduce direct prescriber liability and ensure medication safety. Unlike direct-to-pharmacy models, program-based pricing includes provider oversight, which justifies higher monthly costs but may improve adherence and adverse event management.
Medication Cost Breakdown: Injectable vs. Oral Formulations
GLP-1 medication costs vary significantly by formulation type and pharmacy channel. Injectable medications (semaglutide, tirzepatide) typically cost more per dose than oral alternatives, but onset of action and patient tolerability differ. Understanding these cost-benefit differences helps providers and patients align treatment choice with both budget and clinical goals.
| Medication Type |
Typical Monthly Cost Range |
Formulation Advantage |
Common Use Case |
| Compounded Semaglutide (injectable) |
$149 |
Faster GI effect; familiar dosing escalation |
First-time GLP-1 users; dose titration needed |
| Compounded Tirzepatide (injectable) |
$249 |
Dual GIP/GLP-1 receptor action; once-weekly dosing |
Higher efficacy target; prior GLP-1 exposure |
| Compounded Oral Semaglutide |
$209–$279 |
Needle-free alternative; convenient dosing |
Needle-averse patients; stable maintenance dosing |
| Compounded Oral Tirzepatide |
$279 |
Highest cost range; emerging oral formulation |
Patient preference for oral; variable bioavailability factors |
How Genetic Predisposition Data Influences Long-Term Cost Efficiency
Genetic variants in GLP-1 and GIP receptor pathways (such as GLP1R rs6923761 and GIPR rs1800437) may influence individual medication response rates and optimal dosing strategies. Preliminary evidence suggests patients with certain predispositions achieve target weight loss on lower doses, potentially reducing overall monthly medication costs without sacrificing efficacy.
The Precision Peptide Genetic Test reveals predispositions in peptide receptor and appetite-regulation pathways that may help providers optimize medication selection and dosing from the start. This data can support more informed conversations about whether a lower-cost option like oral semaglutide might work well for your genetic profile, or whether a higher-potency drug like tirzepatide offers better value given your metabolic predispositions.
Insurance Coverage, Out-of-Pocket Costs, and Provider Decision Framework
Insurance coverage for GLP-1 medications varies widely based on FDA-approved indication (diabetes vs. weight management) and formulary placement. Many plans require prior authorization, step therapy, or higher copays for weight management use, pushing patients toward out-of-pocket payment or compounded alternatives, which may not be covered but often cost less upfront.
When evaluating total cost versus clinical benefit, patients should work with their provider to clarify: medication type (injectable vs. oral), starting and target doses, anticipated treatment duration, and whether genetic biomarker data supports a lower-cost formulation. This framework helps distinguish between program fees, medication costs, and ancillary expenses, ensuring transparent financial planning and alignment with health outcomes.
Safety Considerations and Who Qualifies for GLP-1 Treatment
GLP-1 medications carry contraindications (personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia type 2) and common side effects (nausea, vomiting, pancreatitis risk) that require baseline screening and ongoing monitoring. Telemedicine programs vary in depth of contraindication assessment; thorough initial evaluation by a qualified provider is essential regardless of treatment channel or cost tier.
Eligibility typically requires BMI ≥30 kg/m² (or ≥27 with comorbidities) for weight management use, or T2DM diagnosis for glycemic control indication. Before committing to any program—including those with lower fees—ensure your provider conducts adequate medical history, vital signs review, and counseling on realistic outcomes, potential side effects, and long-term commitment, which collectively reduce safety risk and treatment abandonment.
How PlexusDx Supports a More Personalized Approach
PlexusDx genetic testing may help provide context about your individual predispositions in GLP-1 receptor (GLP1R), GIP receptor (GIPR), and appetite-regulation pathways (FTO, MC4R variants). This data should be interpreted with a qualified healthcare provider to explore whether your genetic profile might support more efficient dosing or formulation choice, potentially optimizing both clinical response and cost-effectiveness over time.
The Precision Peptide Genetic Test is a standalone assessment ($298) or add-on to any medication order ($99). It reveals genetic predispositions—not guaranteed medication response or exact outcomes—in peptide signaling and metabolic pathways relevant to GLP-1 and GIP receptor function. This information can complement standard clinical evaluation and help providers make more informed recommendations about which compounded medication formulation and starting dose may align with your biology.
Understanding your genetic predispositions in peptide pathways can support a more informed conversation with your provider about whether a lower-cost option like compounded oral semaglutide ($249/mo) might be effective for you, or whether a higher-potency alternative like compounded tirzepatide ($249/mo) offers better clinical value given your individual profile. Neither cost nor genetics alone determines the right choice—provider guidance, medical history, and realistic outcome expectations are essential.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose Glp1 Protocol starts at $129/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the average total monthly cost of Fella Health treatment?
Fella Health costs typically range $250–$400 monthly, including a $100–$150 consultation fee and $150–$250 medication expense. Exact pricing varies by insurance coverage, program tier, and regional pharmacy rates. Contact their customer service for current rates in your area.
Do insurance plans cover Fella Health consultations and medications?
Insurance coverage depends on your plan's formulary and indication (diabetes vs. weight management). Many plans require prior authorization or step therapy, increasing out-of-pocket costs. Telemedicine programs often work with insurance but do not guarantee coverage—verify with your plan directly.
How does PlexusDx compounded GLP-1 pricing compare to Fella Health?
PlexusDx compounded semaglutide costs $149/mo and compounded tirzepatide $249/mo, with no separate consultation fee. Pricing is transparent and includes access to the Precision Peptide Genetic Test ($99 add-on). Work with your provider to ensure compounded medications align with your clinical needs and coverage.
Can genetic testing help reduce long-term medication costs?
Genetic predisposition data may help providers optimize initial medication selection and dosing, potentially allowing lower-cost formulations to be effective for your unique biology. However, genetics predict predispositions, not exact medication response. Provider guidance based on clinical assessment and trial response remains essential.
What should I consider before choosing between injectable and oral GLP-1 options based on cost?
Oral formulations typically cost $200–$300/mo while injectables range $180–$310/mo depending on type. Efficacy, onset, side effect profile, and needle preference vary by person.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Fridays Pricing: Understanding Cost and Access Models for GLP-1 Treatment
Calibrate Alternatives: Evaluating GLP-1 Options With Genetic Context